Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
MYR Group
MYRG
$4.71B
| $21.7M | 0.01% |
217,969
-174,090
| -44% | -$17.1M |
|
1227
iShares Biotechnology ETF
IBB
$10.9B
| $21.7M | 0.01% |
134,105
-391,394
| -74% | -$65.9M |
|
1228
Innoviva
INVA
$1.52B
| $21.7M | 0.01% |
1,297,110
+599,655
| +86% | +$8.97M |
|
1229
Elevance Health
ELV
$86.9B
| $21.7M | 0.01% |
58,139
-81,527
| -58% | -$31M |
|
1230
CALL
DraftKings
DKNG
$12.9B
| $21.7M | 0.01% |
+450,000
| New | +$23.9M |
|
1231
Centene
CNC
$32.4B
| $21.6M | 0.01% |
347,153
-465,501
| -57% | -$31.1M |
|
1232
Whirlpool
WHR
$2.63B
| $21.6M | 0.01% |
105,787
+9,557
| +10% | +$2.1M |
|
|
DSPG
1233
DELISTED
DSP Group Inc
DSPG
| $21.6M | 0.01% |
984,107
+923,354
| +1,520% | +$16.5M |
|
|
HSKA
1234
DELISTED
Heska Corp
HSKA
| $21.5M | 0.01% |
83,302
+9,961
| +14% | +$2.54M |
|
1235
HubSpot
HUBS
$11.9B
| $21.5M | 0.01% |
31,849
+879
| +3% | +$566K |
|
1236
Steven Madden
SHOO
$3.3B
| $21.5M | 0.01% |
536,078
+348,914
| +186% | +$14.4M |
|
1237
CALL
Global Payments
GPN
$24.9B
| $21.5M | 0.01% |
136,500
+131,700
| +2,744% | +$22.9M |
|
1238
EastGroup Properties
EGP
$10.9B
| $21.5M | 0.01% |
129,003
+103,548
| +407% | +$18M |
|
|
BOAC
1239
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
| $21.5M | 0.01% |
2,191,473
-348,300
| -14% | -$3.41M |
|
1240
PUT
Dollar Tree
DLTR
$25.6B
| $21.5M | 0.01% |
224,200
| – | – |
|
1241
CRISPR Therapeutics
CRSP
$5.91B
| $21.5M | 0.01% |
191,700
+99,061
| +107% | +$12.4M |
|
1242
F5
FFIV
$21.6B
| $21.4M | 0.01% |
107,908
-150,186
| -58% | -$30M |
|
1243
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.76B
| $21.4M | 0.01% |
221,542
-100,105
| -31% | -$8.52M |
|
|
VAQC
1244
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
| $21.4M | 0.01% |
2,195,765
-30,693
| -1% | -$300K |
|
1245
Endava
DAVA
$171M
| $21.4M | 0.01% |
157,467
+31,855
| +25% | +$4.11M |
|
1246
Fortive
FTV
$18.1B
| $21.4M | 0.01% |
402,044
-2,284,089
| -85% | -$125M |
|
|
IPOD
1247
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
| $21.3M | 0.01% |
2,108,888
+1,468,554
| +229% | +$14.8M |
|
1248
Reliance Steel & Aluminium
RS
$19.6B
| $21.3M | 0.01% |
149,664
+119,725
| +400% | +$18M |
|
|
AZUL
1249
DELISTED
Azul
AZUL
| $21.3M | 0.01% |
1,061,769
+969,589
| +1,052% | +$21.3M |
|
1250
Myriad Genetics
MYGN
$298M
| $21.3M | 0.01% |
659,591
-233,929
| -26% | -$7.77M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.